Ben Atkins | Vice President, Communications and Investor Relations |
Roger Crystal | President and Chief Executive Officer |
Matt Ruth | Chief Commercial Officer |
David O'Toole | Chief Financial Officer |
Brandon Folkes | Cantor Fitzgerald |
Carl Byrnes | Northland Capital Markets |
David Bautz | Zacks Small Cap Research |
Mark Walsh | Private Investor |
Good day, ladies and gentlemen and welcome to the Opiant Pharmaceuticals Third Quarter 2021 Financial Results and Business Update Conference Call. At this time all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] I would now like to turn the call over to your host Ben Atkins, Vice President, Communications and Investor Relations of Opiant Pharmaceuticals. Please go ahead.